Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASGARD: Anakinra vs Depo-Medrone for Acute Gout in CKD
NCT02578394Phase 3Completed
- Sponsor
- Mid and South Essex NHS Foundation Trust
- Start
- Apr 2016
- Primary completion
- Jan 2022
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of anakinra in gout, sponsored by Mid and South Essex NHS Foundation Trust. Started Apr 2016; status: completed.
02
Drugs
anakinra
03
Conditions
gout
Beyond the preview
Go deeper on NCT02578394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02578394.